Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062186 · ClinicalTrials.gov registry record · NA
Acute Effects of Naturally Occurring Tea and Coffee-based Ingredients on Cognitive Performance
A NA study of Cognitive Change, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06062186: Completed NA study of Cognitive Change, sponsored by The Center for Applied Health Sciences.
NCT06062186 is a NA study of Cognitive Change that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 40 participants, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062186, a NA study of Cognitive Change, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses including mental clarity, mood, focus, concentration, productivity, anxiety/stress, happiness, and accuracy.
Primary Outcome
Concentration as measured by a traditional 10 cm visual analogue scale (VAS), where values can range from 0 to 10, and higher values represent better concentration.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AmaTea Guayusa Extract
- DIETARY_SUPPLEMENT Lion's Mane
Study Locations (1)
Ohio
- The Center for Applied Health Sciences - Canfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-04-05 |
| Est. Completion | 2023-09-15 |
| Phase | NA |
What the finished NCT06062186 record still lists
NCT06062186 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Cognitive Change appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06062186 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06062186 about?
NCT06062186 is a clinical study titled "Acute Effects of Naturally Occurring Tea and Coffee-based Ingredients on Cognitive Performance". This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses includ...
What is the current status of trial NCT06062186?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-05. Estimated completion is 2023-09-15.
What conditions does trial NCT06062186 study?
This clinical trial studies the following conditions: Cognitive Change.
What interventions are being tested in trial NCT06062186?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AmaTea Guayusa Extract (DIETARY_SUPPLEMENT), Lion's Mane (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06062186?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062186 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06062186's enrollment target sits among peer trials
40 35th of 44 higher than 9 of 44 other Cognitive Change trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Moderators and Mediators of Perceptual Learning
RECRUITING · NA
-
Amplitude Titration to Improve ECT Clinical Outcomes
RECRUITING · NA
-
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
RECRUITING · NA
-
Remote Evaluation of MIND Diet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI